Skip to content
KMC Speciality Hospitals logo

KMC Speciality Hospitals (India)

KMCSHIL NSE
₹150.46 +0.94 (+0.63%)
P/E
43.99
View as Markdown
MCP
Close 4 Nov 2026 ₹150.46 +81.27 +117% 1Y
Start ₹69.19

Key Fundamentals

MicrocapHealthcare ServicesHealthcare

Price-based figures as of · EPS basis: Standalone · TTM

ROCE
26.20%
Debt to Equity
0.40
EPS (TTM)
₹3.42
Book Value
₹12.90
Market Cap
—
P/E (TTM)
43.99
P/B
11.66
ROE
24.90%
Dividend Yield
0.00%
EBITDA
₹93.00 Cr
52W High
₹185.50
52W Low
₹69.02
Day Range
₹148.83 – ₹152.00
Volume
1,36,958

Peer Comparison

Healthcare › Healthcare Services › Hospitals › Hospital

KMC Speciality Hospitals peer comparison
₹8,599.5059.18₹1,22,850 Cr13.040.24%21.20%17.40%₹26,430 Cr₹2,171 Cr
₹927.1561.89₹89,301 Cr7.960.22%14.70%14.70%₹8,712 Cr₹1,457 Cr
₹667.2088.96₹86,479 Cr5.340.00%6.64%8.30%₹11,400 Cr₹906 Cr
₹719.55117.00₹59,927 Cr14.910.44%11.30%11.60%₹4,876 Cr₹363 Cr
₹790.6556.96₹59,706 Cr6.030.13%11.20%13.40%₹9,506 Cr₹1,070 Cr
₹1,931.5048.36₹39,090 Cr7.890.24%20.50%15.50%₹9,072 Cr₹816 Cr
₹1,402.0067.76₹37,618 Cr9.520.04%15.20%17.40%₹4,683 Cr₹552 Cr
₹150.4643.99₹2,459 Cr11.660.00%24.90%26.20%₹331 Cr₹57 Cr
Median 8 companies₹858.9060.54₹59,817 Cr8.740.18%14.95%15.10%₹8,892 Cr₹861 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

64 Good

Data confidence 100/100

Category scores

Quality
83
Strong
Returns, margins, earnings quality 22% weight
Valuation
37
Poor
Cheap vs sector & own history 24% weight
Growth
95
Strong
Sales & profit trajectory 9% weight
Financial Health
65
Good
Solvency, leverage, coverage 9% weight
Momentum
81
Strong
Trend strength, vol-adjusted 12% weight
Ownership
49
Average
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

3
  • Company is expected to give good quarter
  • Company has delivered good profit growth of 29.6% CAGR over last 5 years
  • Company's median sales growth is 22.9% of last 10 years

Weaknesses

2
  • Stock is trading at 13.1 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallBullish577
OscillatorsBearish270
Moving AveragesStrong Bullish307

Key readings

RSI (14)
47.82
Neutral
MACD (12,26,9)
−2.06
Bearish
SMA (50)
151.42
Bearish
SMA (200)
113.93
Bullish

As of

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
10Y+21.68%
5Y+24.33%
3Y+25.18%
1Y+31.90%
TTM+35.10%

Net profit

Net profit growth by window
10Y+31.67%
5Y+29.31%
3Y+20.29%
1Y+123.81%
TTM+128.00%

Operating cash flow

Operating cash flow growth by window
10Y+29.40%
5Y+24.89%
3Y+35.15%
1Y+36.21%
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
10Y+10.16 pp
5Y+6.43 pp
3Y+1.84 pp
1Y+4.19 pp
TTM+5.72 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹55.00 Cr
Mar 2018₹71.00 Cr
Mar 2019₹82.00 Cr
Mar 2020₹96.00 Cr
Mar 2021₹103 Cr
Mar 2022₹136 Cr
Mar 2023₹156 Cr
Mar 2024₹177 Cr
Mar 2025₹232 Cr
Mar 2026₹306 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017₹5.00 Cr
Mar 2018₹7.00 Cr
Mar 2019₹9.00 Cr
Mar 2020₹12.00 Cr
Mar 2021₹13.00 Cr
Mar 2022₹24.00 Cr
Mar 2023₹27.00 Cr
Mar 2024₹30.00 Cr
Mar 2025₹21.00 Cr
Mar 2026₹47.00 Cr

Quarterly Results

₹ Cr
524520 quarterly results, ₹ crore
Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
41
42
49
45
53
56
61
61
67
75
82
82
92
Expenses
31
31
35
33
40
44
45
46
50
54
57
56
63
Operating Profit
10
11
14
12
13
13
16
15
16
21
25
26
28
OPM %
25%
26%
29%
26%
24%
22%
26%
25%
25%
28%
30%
31%
31%
Other Income
2
1
1
1
1
0
1
1
1
1
1
2
2
Interest
0
0
0
0
2
3
2
2
2
2
2
2
2
Depreciation
2
2
2
3
4
5
5
5
5
5
5
6
6
PBT
9
9
12
9
7
5
10
9
10
15
18
20
22
Tax %
26%
26%
24%
25%
26%
27%
25%
49%
25%
26%
26%
26%
26%
Net Profit
7
7
9
7
6
4
8
5
8
11
14
15
17
EPS (₹)
0.43
0.42
0.58
0.43
0.34
0.24
0.46
0.28
0.46
0.66
0.84
0.9
1.02

Profit & Loss

₹ Cr
524520 profit and loss, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
36
43
55
71
82
96
103
136
156
177
232
306
331
Expenses
31
35
42
56
66
75
79
99
114
129
174
217
231
Operating Profit
6
8
12
14
16
21
23
37
42
48
57
88
100
OPM %
16%
19%
23%
20%
20%
22%
23%
28%
27%
27%
25%
29%
30%
Other Income
0
1
0
0
2
1
2
2
3
4
3
5
6
Interest
2
2
1
1
1
1
1
1
1
2
10
9
8
Depreciation
4
3
3
4
4
5
6
7
8
9
19
22
22
PBT
0
4
8
10
12
17
18
32
36
41
32
63
75
Tax %
0%
21%
33%
32%
30%
30%
29%
26%
26%
25%
32%
26%
—
Net Profit
0
3
5
7
9
12
13
24
27
30
21
47
56
EPS (₹)
0.01
0.2
0.33
0.41
0.53
0.72
0.78
1.46
1.64
1.86
1.31
2.87
3.42
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—

Balance Sheet

₹ Cr
524520 balance sheet, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
16
16
16
16
16
16
16
16
16
16
16
16
Reserves
−6
−3
8
14
23
34
47
70
97
127
148
194
Borrowings
14
10
6
15
10
9
29
29
50
82
89
84
Other Liabilities
7
6
8
8
10
11
13
13
18
38
32
38
Total Liabilities
31
29
38
53
60
70
105
129
182
264
286
332
Fixed Assets
25
23
24
37
36
39
74
75
84
206
248
248
CWIP
0
0
0
0
0
0
2
6
34
1
0
0
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
6
7
14
16
24
31
29
48
63
57
38
84
Total Assets
31
29
38
53
60
70
105
129
182
264
286
332

Cash Flow

₹ Cr
524520 cash flow, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
5
6
10
12
16
11
26
29
32
38
58
79
Investing
−1
−1
−4
−19
−9
−8
−43
−29
−48
−56
−51
−17
Financing
−5
−5
−5
6
−5
−4
18
−1
16
20
−2
−21
Net Cash Flow
0
0
1
−1
1
−1
1
0
0
3
4
41
Free Cash Flow
5
5
6
−3
13
7
−15
16
−12
−37
−6
63
CFO/OP
112
91
94
100
113
66
120
102
100
101
112
99

Ratios

524520 financial ratios, annual
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
12
13
12
13
8
8
9
10
10
9
9
9
Inventory Days
42
32
28
24
29
59
39
33
36
31
38
31
Days Payable
169
158
134
143
161
115
117
96
102
113
153
82
Cash Conversion Cycle
−115
−112
−94
−107
−125
−48
−68
−53
−56
−73
−105
−42
Working Capital Days
−70
−60
−46
−37
−28
−18
−15
−27
−22
−73
−22
−19
ROCE %
8%
24%
35%
29%
29%
33%
25%
32%
27%
22%
17%
26%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view KMC Speciality Hospitals insights

63 extracted metrics across FY10–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 75.00%
  • Public 22.03%
  • Others 2.95%
  • FIIs 0.02%

No promoter shares pledged as of 14 Oct 2026

Change since Jun 2026

Documents

  • Q1 FY27 concall · Aug 2026
    PPT
  • Concall · Jun 2026
    PPT
  • Q3 FY26 concall · Mar 2026
    PPT
  • Q2 FY26 concall · Nov 2025
    PPT
  • Q1 FY26 concall · Sep 2025
    PPT

Frequently Asked Questions about KMC Speciality Hospitals (India)

What does KMC Speciality Hospitals (India) Ltd do?
Incorporated in 1982, KMC Speciality Hospitals (India) is in the healthcare sector running, operating, maintaining multi-specialty hospital in Trichy. The company belongs to the Kauvery Hospitals group. The Company is primarily engaged in the business of rendering medical and healthcare services.
Where is KMC Speciality Hospitals (India) Ltd (KMCSHIL) listed?
KMC Speciality Hospitals (India) Ltd trades as KMCSHIL on the NSE and under code 524520 on the BSE.
Which sector does KMC Speciality Hospitals (India) Ltd belong to?
KMC Speciality Hospitals (India) Ltd is classified under the Healthcare Services sector, in the Hospitals industry.
What is the PE ratio of KMC Speciality Hospitals (India) Ltd?
KMC Speciality Hospitals (India) Ltd trades at a PE ratio of 43.99 as of 4 Nov 2026, on earnings per share of ₹3.42, against a book value of ₹12.9 per share.
What is the 52-week high and low of KMC Speciality Hospitals (India) Ltd?
Over the last 52 weeks KMC Speciality Hospitals (India) Ltd has traded between ₹69.02 and ₹185.5 as of 4 Nov 2026.
What is the Return on Equity (ROE) of KMC Speciality Hospitals (India) Ltd?
KMC Speciality Hospitals (India) Ltd reported a return on equity of 24.90%. Its debt-to-equity ratio is 0.40.

Company Information

Incorporated in 1982, KMC Speciality Hospitals (India) is in the healthcare sector running, operating, maintaining multi-specialty hospital in Trichy. The company belongs to the Kauvery Hospitals group. The Company is primarily engaged in the business of rendering medical and healthcare services.

Listed 17 Aug 2026
Face Value ₹1

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/524520.md for KMC Speciality Hospitals (India) Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More